Parenteral Drugs (India) Ltd.
Snapshot View

3.20 0.00

30 September 2022, 03:40:04 PM
Volume: 200

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pdindia.com
Market Cap 9.54 Cr.
Enterprise Value(EV) 116.74 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -25.61 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 31.52 Trailing Twelve Months Ending 2022-03
Book Value / Share -278.81 Trailing Twelve Months Ending 2022-03
Price to Book Value -0.01 Calculated using Price: 3.20
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 2.98 Cr. 29,816,300 Shares
FaceValue 10
Company Profile
Established in the year 1983, Parenteral Drugs has dedicated itself to the manufacturing of the best quality vital life saving drug at the lowest possible cost. Over the years, its path breaking innovation has led not only to lower costs but better quality as well because PDPL firmly believes that better quality dose not necessarily mean higher price, it can also be achieved by indigenous techniques and innovative technologies.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-7.25%
1 Month
-1.54%
3 Month
-28.09%
6 Month
-11.11%
1 Year
+12.28%
2 Year
+23.08%
5 Year
-81.92%
10 Year
-95.85%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -44.85 -23.61 -46.67 -152.43
Return on Capital Employed (%) -5.15 1.90 -2.29 -8.13 -6.91 -5.55 -35.07 -52.31
Return on Assets (%) -12.80 -5.44 -8.41 -12.60 -12.16 -13.17 -23.45 -26.72 -29.65

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 246 202 127 325 -17 -136 -447 -561 -683 -824
Non Curr. Liab. 427 456 427 440 462 370 4 -26 -59 -91
Curr. Liab. 162 166 230 300 428 593 878 1,006 1,144 1,201
Minority Int. 1 1 1 1 0 0 0 0 0 0
Equity & Liab. 835 825 785 1,066 872 827 435 419 402 286
Non Curr. Assets 629 619 549 902 750 727 368 351 334 219
Curr. Assets 192 200 235 163 122 99 67 67 68 67
Misc. Exp. not W/O 14 5 1 1
Total Assets 835 825 785 1,066 872 827 435 419 402 286

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 327 274 263 260 230 224 32 32 12 9
Other Income 0 61 1 2 6 2 1 0 0 0
Total Income 328 334 264 262 236 226 33 32 12 9
Total Expenditure -341 -350 -248 -296 -252 -225 -50 -47 -24 -24
PBIDT -14 -15 15 -34 -17 0 -16 -14 -12 -16
Interest -56 -60 -70 -70 -86 -98 -96 -110 -125 -106
Depreciation -23 -19 -31 -23 -25 -24 -69 -17 -17 -40
Taxation -15 1 19 10 10 10 33 28 33 33
Exceptional Items 47 0 -1 0 52
PAT -108 -45 -68 -117 -118 -112 -148 -114 -122 -76
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -108 -45 -68 -117 -118 -112 -148 -114 -122 -76
Adjusted EPS -42 -15 -23 -39 -40 -38 -50 -38 -41 -26

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 20 -168 -60 2 58 134 167 477 112 125
Cash Fr. Inv. -147 -18 33 3 -110 -1 -1 97 0 0
Cash Fr. Finan. 133 182 25 -10 54 -134 -167 -574 -112 -125
Net Change 5 -3 -2 -5 1 0 0 0 0 0
Cash & Cash Eqvt 13 11 8 3 5 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 73.28 73.28 73.28 73.28 73.28 73.28 73.28 73.28 73.29
Public 26.72 26.72 26.72 26.72 26.72 26.72 26.72 26.72 26.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 100.00 100.00 100.00 94.51 94.51 94.51 94.51 94.51 94.50

Announcements View Details >>

Thu, 25 Aug 2022
Communication to shareholders as per Reg 30
Parenteral Drugs (India) Limited has informed the Exchange about communication to shareholders as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding update on the operations of the Company.
Wed, 24 Aug 2022
Communication to shareholders as per Reg 30
Parenteral Drugs (India) Limited has informed the Exchange about communication to shareholders as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding update on the operations of the Company.
Thu, 11 Aug 2022
Resignation
Parenteral Drugs (India) Limited has informed the Exchange about resignation of Pooja Choukse as Company Secretary of the company w.e.f. 31-Jul-2022.

Technical Scans View Details >>

Fri, 30 Sep 2022
Opening at High Opening at High
Opening at Low Opening at Low
High Decrease 3 Months High Decrease 3 Months
ROC Trending Up ROC Trending Up
Thu, 29 Sep 2022
Close Crossing Last Month Low Close Crossing Last Month Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 227,696.89 949.00 +2.0%
Divi's Laboratories Ltd. 97,811.90 3,684.50 -0.2%
Cipla Ltd. 89,996.82 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. 72,145.56 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. 62,833.90 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. 52,506.43 1,551.40 +0.3%
Abbott India Ltd. 40,438.70 19,030.60 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.54 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-06 36.17 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.12 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.12 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.55 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-06 50.01 19,030.60 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.54 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-06 4.19 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.56 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.57 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.21 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-06 13.56 19,030.60 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 19,030.60 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 19,030.60 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 19,030.60 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,030.60 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 19,030.60 -0.8%

FAQ's On Parenteral Drugs (India) Ltd.

What is Parenteral Drugs share price?

Can I buy Parenteral Drugs shares now?

What is the Market Cap of Parenteral Drugs?

What is the 52 Week High and Low of Parenteral Drugs?